Abstract Lafora progressive myoclonus epilepsy (Lafora disease, LD) is a fatal rare autosomal recessive neurodegenerative disorder characterized by the accumulation of insoluble ubiquitinated polyglucosan inclusions in the cytoplasm of neurons, which is most commonly associated with mutations in two genes: EPM2A, encoding the glucan phosphatase laforin, and EPM2B, encoding the E3-ubiquitin ligase malin. The present study analyzes possible inflammatory responses in the mouse lines Epm2a −/− (laforin knock-out) and Epm2b
Introduction
Lafora progressive myoclonus epilepsy (Lafora disease, LD, OMIM 254780, ORPHA501) is a fatal rare autosomal recessive neurodegenerative disorder, which usually occurs during childhood. It is characterized by generalized tonic-clonic seizures, myoclonus, absences, drop attacks, and visual seizures. As the disease progresses, patients present a rapid progressive dementia concomitant with an amplification of seizures, leading to death within a decade after the first symptoms [1, 2] . The hallmark of the disease is the accumulation of insoluble polyglucosan inclusions, called Lafora bodies (LBs), in the cytoplasm of neurons and other cells in peripheral tissues. In the vast majority of patients LD has been associated with mutations in two genes: EPM2A, encoding the glucan Irene López-González and Rosa Viana contributed equally to this work.
* Pascual Sanz sanz@ibv.csic.es * Isidre Ferrer 8082ifa@gmail.com phosphatase laforin, and EPM2B, encoding the E3-ubiquitin ligase malin. Although laforin and malin may have independent functions, it has been shown that they form a functional complex in which laforin acts as scaffold and recruits specific substrates to be ubiquitinated by malin. It has also been demonstrated that laforin and malin regulate glycogen synthesis, either by affecting the activity of proteins involved in this process [3] [4] [5] [6] or by laforin acting as a glycogen phosphatase and thus being able to dephosphorylate complex glucans [7] [8] [9] . This would explain why the absence of laforin or malin leads to aberrant glycogen accumulation in neurons in the form of LBs, which are glycogen-like inclusions with a greater degree of phosphorylation and less branching than normal glycogen. Hence LBs are largely insoluble. Recent work has demonstrated that neuronal death in LD can be influenced not only by the accumulation of LBs but also by impairment in mechanisms related to protein clearance. For instance, endoplasmic reticulum stress is significantly increased in mouse models of LD [10] [11] [12] [13] , and molecular interactions between laforin, malin and the chaperone, and proteasome systems [14, 15] have been described. This body of evidence points to a critical dysregulation of cellular protein homeostasis in LD that goes beyond alterations in glycogen metabolism regulation. In this sense, our previous work with mouse models of LD such as Epm2a −/− [16] and Epm2b −/− [17] revealed impairment of autophagy and defects in the ubiquitin-proteasome system [12, 18] which correlated with neurological and behavioral abnormalities. We have also described increased oxidative stress and impaired antioxidant response in LD cellular and mouse models [19] , thus suggesting that oxidative stress is a new hallmark in the pathogenesis of LD [20] . These results are in agreement with the hypothesis that defects in autophagy and protein clearance are related with an increase in reactive oxygen species (ROS) production and consequent oxidative stress [21] [22] [23] [24] . It is feasible that alterations in protein homeostasis and oxidative stress could underlie the appearance of reactive astrogliosis observed in different brain areas of malin knock-out (Epm2b −/− ) mice [25, 26] . Microglia activation and neuroinflammatory responses are currently observed in most neurodegenerative diseases and they are determinants in the pathogenesis of these processes [27] [28] [29] [30] . However, very little is known about inflammatory responses and most particularly about gene modulation of cytokines and mediators of the immune response along with disease progression in LD. The present study is focused on possible inflammatory responses in the brain of laforin knock-out (Epm2a −/− ) and malin knock-out (Epm2b −/− ) mice to learn whether inflammation plays a role in the pathogenesis of LD, in the same way that inflammation has functional implications in the pathogenesis of neurodegenerative diseases with abnormal protein aggregates. Male mice of 16 days, 3 months, and 12 months of age were sacrificed by cervical dislocation. Brain was recovered and the two hemispheres separated, one conserved at −80°C for processing for Western blot and qPCR analyses, and the other fixed in 4 % paraformaldehyde in phosphate buffer saline (PBS) for immunohistochemical analyses.
Material and Methods

Immunohistochemical Analyses
Dehydrated tissues from at least three independent mice per group were embedded in paraffin and sectioned at 4 μm. Some sections were stained with periodic acid Schiff (PAS). Other sections were de-waxed, rehydrated, and warmed at 95°C for 30 min in 10 mM citrate buffer for antigen retrieval. Sections were blocked in blocking buffer (1 % bovine serum albumin; 5 % fetal bovine serum in PBS) and incubated overnight at 4°C with the appropriate primary antibody diluted in blocking buffer: anti-GFAP (diluted 1/300; Sigma ref. CA, USA) using diaminobenzidine as chromogenic substrate for peroxidase (Peroxidase substrate kit DAB; Vector Laboratories, Burlingame, CA, USA). Sections were slightly counterstained with hematoxylin (Sigma, Madrid, Spain), dehydrated, and mounted in DPX (Merck, Germany). Images were acquired by light microscopy (Leica DM RXA2, Leica Microsystems, Wetzlar, Germany) and analyzed with Image J software (NIH, Bethesda, MD, USA). The intensity of the signal was quantified using the Image J software in an area of 0.17 mm 2 located between the dentate gyrus and the CA1 region of the hippocampus, and expressed as the number of pixels/mm 2 . The significance level (Student's t test) was set at *p < 0.05, **p < 0.01, and ***p < 0.001.
RNA Purification
Total RNA from the posterior part of the neocortex and hippocampus of WT, Epm2a Table 1 . The mean values of the three house-keeping genes, hypoxanthine-guanine phosphoribosyltranferase (Hprt), alanyl-transfer RNA synthase (Aars), and X-prolyl aminopeptidase (aminopeptidaseP) 1 (Xpnpep1), were used as internal controls for normalization. The reactions were carried out using the following parameters: 50°C for 2 min, 95°C for 10 min, and 40 cycles of 95°C for 15 sec and 60°C for 1 min. Finally, all TaqMan PCR data were captured using the Sequence Detection Software (SDS version 2.2.2, Applied Biosystems). Samples were analyzed with the double-delta cycle threshold (ΔΔCT) method. Results were analyzed with two-way ANOVA followed by Tukey's post hoc or Student's t test when required. The significance level was set at *p < 0.05, **p < 0.01, and ***p < 0.001.
Western Blotting
Mouse brain homogenates were lysed in RIPA buffer (50 mM Tris-HCl, pH 7.0; 150 mM NaCl, 1 % Nonidet P-40; 0.5 % Na-deoxycholate; 0.1 % SDS) supplemented with protease and phosphatase inhibitors (Roche, Germany 
Results
Lafora Inclusions in the Telencephalon in Epm2a
−/− and Epm2b −/− Mice A few PAS-positive round or elongated inclusions in the neuropil and more rarely in the neuronal cytoplasm were first seen in transgenic mice aged 3 months. The number and size of the inclusions was higher in Epm2a −/− and Epm2b −/− mice aged 12 months as detailed elsewhere [16, 17] . Examples of these deposits are shown in Fig 1 . Chemokine (C-C motif) ligand 3 Mm00441258_m1
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Transforming growth factor β2 Mm00436955_m1 mice. First, we analyzed the regular age-dependent changes in the expression of these genes in wild-type mice: we found that C3ar1, C4b, Csf3r, Ccl6, CxCl10, Il6, Il6st, Tnfrsf1a, Il10ra, and Il10rb messenger RNA (mRNA) expression levels significantly increased and C1ql1 levels significantly decreased in WT mice of 3 months of age when compared with WT mice aged 16 days. The differences in the expression levels of these genes further increased in WT mice aged 12 months when compared with mice aged 16 days; in addition, Ccl3, Ccl4, Tlr4, and Tnfα mRNA expression was higher in WT mice aged 12 months when compared with mice aged 16 days.
However, Tgf-β1 decreased with age. Increased expression with age was supported to a greater extent by the fact that C4b, Ccl3, Ccl4, Ccl6, CxCl10, Il6, and Tnfα were significantly increased in WT mice aged 12 months when compared with WT mice 3 months old (Table 2 ). In the case of Epm2a −/− mice, C3ar1, Csf3r, Ccl4, Il1b, Il6st, Il10ra, and Il10rb mRNAs were increased and C1ql1 mRNA was decreased in mice aged 3 months when compared with mice aged 16 days. Moreover, C3ar1, C4b, Csf1r, Csf3r, Tlr4, Ccl4, Ccl6, CxCl10, Il1b, Il6, Tnfα, Il10ra, and Il10rb mRNAs were significantly increased in Epm2a −/− aged 12 months when compared with Epm2a −/− aged 16 days.
C1ql1 mRNA also significantly decreased in Epm2a −/− mice (Table 2) .
Differential Gene Expression of Cytokines and Mediators of the Inflammatory Response in Epm2a
−/− and Epm2b
Mice Compared with WT Mice
Then, we analyzed the differences in gene expression at the different ages between wild-type, Epm2a
, and Epm2b
mice. Few differences were seen in Epm2a −/− (laforin knockout) and Epm2b −/− (malin knock-out) mice aged 16 days when compared with age-matched WT littermates; we found a small increase in the expression of Il6 and Tnfα in Epm2a −/− mice and a small increase in the expression of C1qtnf7, Csf3r, and Il6 in Epm2b −/− mice at this age (Table 2 ). At 3 months of age we found an increase in the expression of Ccl4, CxCl10, and Il6st in Epm2a −/− mice, and of CxCCl10 and Tnfα in Epm2b −/− mice (Table 2 ). In contrast, a significant reduction of Ccl4 and Il10ra occurred in Epm2b −/− when compared with Epm2a −/− mice at this age. However, a dramatic gene upregulation was found in Epm2b −/− mice at the age of 12 months when compared with the limited change in Epm2a −/− mice at a similar age. Whereas only C3ar1, Csf3r, and CxCl10 mRNA expression was increased in Epm2a −/− in comparison to WT, the expression of C3ar1, C4b, Ccl4, Ccl6, CxCl10, Il1b, Il6, Tnfα, and Il10ra was upregulated in Epm2b −/− aged 12 months when compared with age-matched WT ( Table 2 ). All these results are compatible with the presence of inflammation in the brain of LD mice at 3 months of age becoming aggravated as the mice aged, with the phenotype more severe in the case of Epm2b −/− mice. In fact, C3ar1, Ccl4, Ccl6, CxCl10, Il1b, Tnfα, and Il10ra mRNA expression was significantly upregulated in Emp2b −/− mice aged 12 months when compared with Epm2a −/− mice of the same age (Table 2) .
Protein Expression of Selected Cytokines and Mediators
In order to confirm the inflammatory process present in the brain of Epm2a −/− and Epm2b −/− mice, IL1-β, IL6, and TNFα protein levels were analyzed by Western blotting in brain extracts from wild-type, Epm2a
, and Epm2b −/− mice aged 16 days, 3 months, and 12 months, respectively. As shown in Fig. 4 , at 16 days of age Epm2b −/− mice showed an increase in the levels of IL1-β and IL6 in comparison to WT mice. No differences were observed in the case of Epm2a −/− mice. At 3 months of age, we found in Epm2b −/− mice a tendency to higher levels of IL1-β and IL6 and a significant increase in the levels of TNFα in comparison to WT of the same age. However, Epm2a −/− mice showed similar protein levels of IL1-β and IL6 and reduced levels of TNFα at this age in comparison to WT. At 12 months of age, Epm2b −/− mice showed higher levels of IL1-β and IL6 but similar levels of TNFα in comparison to WT of the same age. In contrast, Epm2a −/− mice showed levels of IL1-β, IL6, and TNFα similar to WT. These data confirm that Epm2b −/− mice present a more severe inflammatory pattern than Epm2a −/− mice.
In addition, we analyzed the levels of cyclooxygenase 2 (Cox2), a target gene of inflammatory mediators. An immunohistochemical analysis of the hippocampus of WT, Epm2a ) mice used in the present study [17, 31] start to develop LBs in the cerebral cortex, hippocampus, basal ganglia, thalamus, cerebellum, cerebellar nuclei, and brain stem at about the first month of age, and this increases in number and size with disease progression. LBs are very abundant in these regions at advanced stages of the disease [17, 31, 32] . Deposits are also found in the choroid plexus but the olfactory bulb is largely spared. Although both mouse lines have clinical symptoms similar to those seen in human LD, Epm2b −/− mice show some differences in comparison to Epm2a −/− mice such as reduced accumulated motor surface, rearing and stereotyped activity, as well as lower episodic memory deficits and nonspatial memory skills. In addition, although both mouse lines have tonic-clonic seizures, these occur in parallel with spikewave, poly-spikes, and poly-spike-wave complexes in Epm2a −/− mice but there are no EEG correlates in Epm2b −/− mice [32] . All these data suggest that the phenotype observed in Epm2b −/− mice is more severe than that presented in
In this study, we investigated whether neuroinflammation is a novel hallmark in Lafora disease. With this aim, we analyzed how the expression of a panel of cytokines and mediators of the inflammatory response changes with age in WT, Epm2a −/−, and Epm2b −/− mice. It is known that marked modification of the profile of gene expression of cytokines and molecules linked with the inflammatory response occurs in the cerebral cortex and other brain regions of mice with age. This happens in normal aging and also in transgenic mice including APP/PS1, P301S-MAPT, and S49P-Syracuse human neuroserpin (S49P-Syracuse), and in CJD-induced prionopathy in murine PrP-null mice expressing human PrP, which are models of human β-amyloidopathy reminiscent of Alzheimer disease, familial frontotemporal degenerationtauopathy (FTLD-tau), neuroserpinopathy, and CreutzfeldtJakob disease, respectively [33] [34] [35] [36] . This pattern is repeated in our study as C3ar1, C4b, Csf3r, Tlr4, Ccl4, Ccl6, CxCl10, Il1b, Il6, Tnfα, Il10ra, and Il10rb mRNA expression levels . It can be suggested that unexpected reduced TNFα protein expression is related to epigenetic regulation. However there is no available information about non-coding RNAs in LD and related transgenic models. An explanation of this punctual finding at the age of 3 months in Epm2a −/− is not known. In agreement with increased expression of cytokines and mediators of the immune response in both LD mouse models, we found increased levels of Cox2, a protein with pro-inflammatory properties, in both [37] , but chronic inflammation, involving chemokines, pro-inflammatory cytokines, anti-inflammatory cytokines, and members of the complement system, is usually associated with nerve cell damage in human neurodegenerative diseases with abnormal protein aggregates and in related animals models. The observations presented in this study are particularly relevant since increased microglia and marked increase in mRNA and protein expression of cytokines and mediators of the inflammatory response are described for the first time in LD, a paradigm of polyglucosan disease. Insoluble phosphorylated polyglucosans, endoplasmic reticulum stress, oxidative stress, altered autophagy, and ubiquitin-proteasome activity may all contribute to the inflammatory response. Since inflammatory responses appear at relatively early stages of LD, the administration of anti-inflammatory agents may be considered a possible treatment in order to delay brain damage.
